Immunization, Vaccines and Biologicals

Global Vaccine Action Plan 2011-2020

Full document and summary

Cover of Global Vaccine Action Plan document

The Global Vaccine Action Plan (GVAP) ― endorsed by the 194 Member States of the World Health Assembly in May 2012 ― is a framework to prevent millions of deaths by 2020 through more equitable access to existing vaccines for people in all communities.

GVAP was the product of the DoV Collaboration, an unprecedented effort that brought together development, health and immunization experts and stakeholders. The leadership of the Bill & Melinda Gates Foundation, GAVI Alliance, UNICEF, United States National Institute of Allergies and Infectious Diseases and WHO, along with all partners – governments and elected officials, health professionals, academia, manufacturers, global agencies, development partners, civil society, media and the private sector – are committed to achieving the ambitious goals of the GVAP. Many more are expected to add their support in the future as the plan is translated and implemented at the country and regional levels.

Download the full GVAP

Download the GVAP by section

1. Foreword

2. The Global Vaccine Action Plan

Introduction and Immunization Landscape Today
Guiding principles, Measures of Success and Goals
Six strategic objectives
Health returns on investment in immunization
Continuing momentum for the Decade of Vaccines

3. GVAP World Health Assembly Resolution

4. Annexes

1: Recommended Indicators
2: Stakeholder Responsibilities
3: Costing and Funding Methodology and Assumptions
4: Health Impacts and Methodology Assumptions
5: Countries and Organizations that Contributed to the Elaboration of the GVAP
6: The Monitoring and Evaluation/Accountability Framework

5. Acknowledgements and contact

Background information

Decade of Vaccines Collaboration
The DoV Collaboration brought together diverse stakeholders to develop the GVAP to stimulate the discovery, development and delivery of lifesaving vaccines. The plan builds on the success of current work to transform the way vaccines move from formulation, to factory, to families.